ICICI Pru Nifty Pharma Index Fund Reg G
Summary Info
Fund Name
:
Scheme Name
: ICICI Pru Nifty Pharma Index Fund Reg G
AMC
:
Type
: Open
Category
:
Launch Date
: 03-Sep-2026
Fund Manager
:
Net Assets (Rs. cr)
:
ICICI Pru Nifty Pharma Index Fund Reg G - Nav Details
Nav Date
: 02-Sep-2026
NAV [Rs.]
: 20.2572
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
ICICI Pru Nifty Pharma Index Fund Reg G- NAV Chart
ICICI Pru Nifty Pharma Index Fund Reg G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.85 | 0.93 | 10.69 | 16.42 | 22.37 | 20.56 | - | 20.92 |
| Category Avg | -1.03 | -0.04 | 4.74 | 2.76 | 4.68 | 12.52 | 9.99 | 7.72 |
| Category Best | 2.35 | 6.53 | 16.35 | 23.73 | 36.52 | 29.94 | 17.44 | 28.22 |
| Category Worst | -3.21 | -4.49 | -6.75 | -13.65 | -17.72 | 1.03 | 5.79 | -16.24 |
ICICI Pru Nifty Pharma Index Fund Reg G- Latest Dividends
No Records Found
ICICI Pru Nifty Pharma Index Fund Reg G- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Sai Life20,658
Out
InName Of The CompanyNo Of Shares
J B Chemicals &12,028
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.33 | 158564 | 31.56 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.35 | 19027 | 15.32 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 8.38 | 84259 | 12.41 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 7.60 | 21962 | 11.25 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 7.15 | 58261 | 10.58 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.08 | 91282 | 10.48 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.93 | 36364 | 8.78 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.42 | 41447 | 6.54 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.40 | 8759 | 5.03 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.40 | 22544 | 5.03 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.07 | 106836 | 4.54 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.85 | 37462 | 4.22 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.82 | 16950 | 4.18 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.45 | 20798 | 3.63 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.01 | 11927 | 2.98 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 1.83 | 20658 | 2.71 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.63 | 12362 | 2.42 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.47 | 6302 | 2.18 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.45 | 777 | 2.16 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.23 | 93138 | 1.82 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
ICICI Prudential Mutual Fund
Incorporation Date:
22-Jun-1993
Total Assets Managed (Cr.):
11,76,217.65
Trustee/s:
Mr. Lakshman Kumar Mylava, ICICI Prudential Trust Lt
Chairman:
NA
CEO / MD:
Mr. Nimesh Shah
CIO:
NA
President:
NA
Director/s:
Mr. Vijay Thacker, Mr. Nimesh Shah, Ms. Vibha Paul Rishi, Ms.Anubhuti Sanghai
Compliance Officer/s:
NA
Investor Service Officer/s:
Rajen Kotak
Fund Manager/s:
Nishit Patel
Auditors:
S.R.Batliboi & Co. LLP
OTHER INFORMATION
Registered Office:
One BKC, A-Wing, 13th Floor, Bandra Kurla Complex, Mumbai 400051
Contact Nos:
022 26525000
Fax:
022 26528100
Email:
Website:
